Trials / Conditions / Metabolic Associated Fatty Liver Disease

Metabolic Associated Fatty Liver Disease

18 registered clinical trials studyying Metabolic Associated Fatty Liver Disease — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Glucagon Resistance in Patients With MASLD and T2DM NCT07246421	University of Aarhus	N/A
Recruiting	Evaluation of Non-Invasive Tests for Metabolic Liver Disease NCT07122700	Foundation for the National Institutes of Health	—
Recruiting	To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Dise NCT07149571	Tongji Hospital	—
Recruiting	Effect of Low Valine Diet on Body Weight and Metabolic Parameters NCT06883578	Shanghai Zhongshan Hospital	N/A
Not Yet Recruiting	Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) NCT06764056	Institut universitaire de cardiologie et de pneumologie de Québec, University Laval	N/A
Recruiting	Efficacy and Safety of Rifaximin in Treating MAFLD NCT07185932	Shanghai Changzheng Hospital	EARLY_Phase 1
Unknown	Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surger NCT06180928	Assiut University	—
Completed	Benefits of Trimetazidine in MASLD Patients NCT06140953	October 6 University	Phase 2
Unknown	Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D NCT05140694	Seoul National University Bundang Hospital	Phase 4
Active Not Recruiting	Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot NCT05782972	Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation	Phase 4
Unknown	Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Diseas NCT05913986	Saluz Investigación S. C.	N/A
Unknown	Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease NCT05738707	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	—
Recruiting	Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China NCT05597709	Wuxi Hisky Medical Technology Co Ltd	—
Completed	Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Pat NCT07175688	Tanta University	—
Recruiting	A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China NCT04573283	Nanfang Hospital, Southern Medical University	—
Unknown	Lifestyle Modification for MAFLD Based on TTM NCT04871880	Nanfang Hospital, Southern Medical University	N/A
Completed	MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes NCT04761900	Ningbo No. 1 Hospital	—
Unknown	Clinical Characteristics of Metabolic Associated Fatty Liver Disease NCT06325254	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	—